Ranbaxy Laboratories has entered into an exclusive marketing agreement for
Inersan is used for the treatment of dental problems like periodontitis, gingivitis and halitosis. According to a release issued by Ranbaxy today, there is no drug available for the treatment of these dental problems in the country today.
Tuesday, March 18, 2008
Ranbaxy signs deal with CD Pharma for Inersan
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment